4//SEC Filing
Francis Richard D 4
Accession 0000950170-25-083680
CIK 0000818686other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:01 PM ET
Size
5.8 KB
Accession
0000950170-25-083680
Insider Transaction Report
Form 4
Francis Richard D
President and CEO
Transactions
- Award
Restricted Share Units
2025-06-05+52,173→ 52,173 total→ Ordinary Shares (52,173 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on June 5, 2025, with 13,043 vesting on each of June 5, 2026, June 5, 2027, and June 5, 2028 and 13,044 vesting on June 5, 2029.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001673277
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:01 PM ET
- Size
- 5.8 KB